Champions Oncology, Inc. (CSBR)

Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 21, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Market Capitalization	58	66	67	104	144	92
Market Cap Growth	-25.57%	-1.17%	-35.77%	-27.72%	56.56%	-12.98%
Enterprise Value	63	69	64	105	143	92
Last Close Price	4.32	4.85	4.92	7.68	10.73	7.72
PE Ratio	-	-	-	189.51	396.90	-
Forward PE	29.79	-	-	42.95	77.31	77.20
PS Ratio	1.13	1.31	1.24	2.11	3.50	2.86
PB Ratio	-196.13	-34.65	14.39	11.42	19.34	18.00
P/TBV Ratio	-	-	15.51	11.85	20.26	19.26
P/FCF Ratio	-	-	60.64	25.25	-	133.97
P/OCF Ratio	-	-	16.79	15.98	-	31.59
PEG Ratio	-	-	-	2.86	6.09	5.15
EV/Sales Ratio	1.22	1.38	1.19	2.13	3.48	2.88
EV/EBITDA Ratio	-	-	-	46.90	92.05	-
EV/EBIT Ratio	-	-	-	172.62	389.82	-
EV/FCF Ratio	-	-	58.12	25.48	-	134.98
Debt / Equity Ratio	-21.41	-3.90	1.85	1.04	1.29	0.74
Debt / EBITDA Ratio	11.26	-	-	2.29	3.37	19.58
Debt / FCF Ratio	-	-	7.82	2.30	-	5.54
Asset Turnover	1.88	1.66	1.55	1.56	1.70	2.01
Quick Ratio	0.62	0.56	0.83	1.06	1.04	1.07
Current Ratio	0.69	0.63	0.90	1.13	1.13	1.10
Return on Equity (ROE)	-432.46%	-532.46%	-77.70%	6.63%	5.78%	-57.05%
Return on Assets (ROA)	-6.93%	-14.31%	-7.98%	1.20%	0.95%	-6.19%
Return on Capital (ROIC)	-22.31%	-46.11%	-17.49%	2.13%	1.76%	-17.78%
Earnings Yield	-5.78%	-11.04%	-8.00%	0.53%	0.25%	-2.28%
FCF Yield	-3.41%	-10.58%	1.65%	3.96%	-3.45%	0.75%
Buyback Yield / Dilution	-0.23%	-0.04%	4.37%	2.84%	-23.05%	15.98%
Total Shareholder Return	-0.23%	-0.04%	4.37%	2.84%	-23.05%	15.98%

Source: S&P Capital IQ. Standard template. Financial Sources.